Financial publication Bloomberg BusinessWeek this week profiled the nearly impossible process undertaken by U.S. researchers that would like to conduct studies on medical cannabis, but are prohibited from do so because of federal restrictions on cannabis.
The controversy over medical cannabis research, in the Bloomberg piece, is illustrated by the efforts of Lyle Cracker, a professor who teaches botany at the agricultural college of the University of Massachusetts, Amherst. For 17 years, Cracker has been trying to obtain a federal license to grow “research grade marijuana” for studies. Cracker first applied in 2001 at the urging of Rick Doblin, founder and executive director of nonprofit Multidisciplinary Association for Psychedelic Studies, which advocates for use of alternative drug therapies, including cannabis.
Cracker told Bloomberg that he has never smoked cannabis or even had a drink of alcohol. And he also told them, “I’m never